Leonard Frank X — SEC Form 4 filings
SEC reporting owner CIK 1822879. 16 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-02-29 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 18 legs across 10 filings — 124,836 shares, $2,171,024 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 34,273 shares @ $17.93 ($614,635) in NovoCure Ltd, filed 2026-06-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NovoCure Ltd (NVCR) | Chief Executive Officer | 16 | — | 18 legs · 124,836 sh · $2,171,024 | 12 |
Form 4 filings — Leonard Frank X
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 1,905 @ $11.15 | EDGAR |
| 2026-06-05 | 4 | NovoCure Ltd (NVCR) | Sale (S): 34,273 @ $17.93 | EDGAR |
| 2026-03-05 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 150,000 @ $0 · Sale (S): 5,607 @ $13.31 · Grant/award (A): 216,388 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | NovoCure Ltd (NVCR) | Sale (S): 9,734 @ $13.66 · Grant/award (A): 18,621 @ $0 · Sale (S): 7,232 @ $13.49 | EDGAR |
| 2025-11-04 | 4 | NovoCure Ltd (NVCR) | Tax withholding (F): 966 @ $12.81 | EDGAR |
| 2025-07-01 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 833 @ $15.13 | EDGAR |
| 2025-06-06 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 179,426 @ $0 | EDGAR |
| 2025-06-04 | 4 | NovoCure Ltd (NVCR) | Sale (S): 21,717 @ $17.22 · Sale (S): 6,600 @ $17.99 · Sale (S): 1,879 @ $19.01 | EDGAR |
| 2025-03-06 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 54,975 @ $18.19 · Grant/award (A): 81,499 (derivative) @ $18.19 | EDGAR |
| 2025-03-04 | 4 | NovoCure Ltd (NVCR) | Sale (S): 2,527 @ $18.54 | EDGAR |
| 2025-03-03 | 4/A | NovoCure Ltd (NVCR) | Sale (S): 10,277 @ $19.92 · Sale (S): 1,989 @ $20.55 · Sale (S): 2,770 @ $18.28 | EDGAR |
| 2025-03-03 | 4 | NovoCure Ltd (NVCR) | Sale (S): 10,277 @ $19.92 · Sale (S): 1,989 @ $20.55 · Sale (S): 2,770 @ $18.28 | EDGAR |
| 2024-11-04 | 4 | NovoCure Ltd (NVCR) | Sale (S): 598 @ $15.94 | EDGAR |
| 2024-08-06 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 1,736 @ $12.24 | EDGAR |
| 2024-03-05 | 4 | NovoCure Ltd (NVCR) | Sale (S): 1,679 @ $16.03 · Sale (S): 840 @ $16.01 | EDGAR |
| 2024-02-29 | 4 | NovoCure Ltd (NVCR) | Grant/award (A): 102,249 @ $16.30 · Sale (S): 2,078 @ $16.14 · Grant/award (A): 156,348 (derivative) @ $16.30 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1822879 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →